178 related articles for article (PubMed ID: 28326433)
1. Application of Electronic Algorithms to Improve Diagnostic Evaluation for Bladder Cancer.
Murphy DR; Meyer AN; Vaghani V; Russo E; Sittig DF; Richards KA; Wei L; Wu L; Singh H
Appl Clin Inform; 2017 Mar; 8(1):279-290. PubMed ID: 28326433
[TBL] [Abstract][Full Text] [Related]
2. Computerized Triggers of Big Data to Detect Delays in Follow-up of Chest Imaging Results.
Murphy DR; Meyer AN; Bhise V; Russo E; Sittig DF; Wei L; Wu L; Singh H
Chest; 2016 Sep; 150(3):613-20. PubMed ID: 27178786
[TBL] [Abstract][Full Text] [Related]
3. Electronic Trigger-Based Intervention to Reduce Delays in Diagnostic Evaluation for Cancer: A Cluster Randomized Controlled Trial.
Murphy DR; Wu L; Thomas EJ; Forjuoh SN; Meyer AN; Singh H
J Clin Oncol; 2015 Nov; 33(31):3560-7. PubMed ID: 26304875
[TBL] [Abstract][Full Text] [Related]
4. Development and Validation of Trigger Algorithms to Identify Delays in Diagnostic Evaluation of Gastroenterological Cancer.
Murphy DR; Meyer AND; Vaghani V; Russo E; Sittig DF; Wei L; Wu L; Singh H
Clin Gastroenterol Hepatol; 2018 Jan; 16(1):90-98. PubMed ID: 28804030
[TBL] [Abstract][Full Text] [Related]
5. Electronic health record-based triggers to detect potential delays in cancer diagnosis.
Murphy DR; Laxmisan A; Reis BA; Thomas EJ; Esquivel A; Forjuoh SN; Parikh R; Khan MM; Singh H
BMJ Qual Saf; 2014 Jan; 23(1):8-16. PubMed ID: 23873756
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of Electronic Health Record-based Triggers to Detect Delays in Follow-up of Abnormal Lung Imaging Findings.
Murphy DR; Thomas EJ; Meyer AN; Singh H
Radiology; 2015 Oct; 277(1):81-7. PubMed ID: 25961634
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic evaluation of patients presenting with hematuria: An electronic health record-based study.
Richards KA; Ruiz VL; Murphy DR; Downs TM; Abel EJ; Jarrard DF; Singh H
Urol Oncol; 2018 Mar; 36(3):88.e19-88.e25. PubMed ID: 29169843
[TBL] [Abstract][Full Text] [Related]
8. Electronic Triggers to Identify Delays in Follow-Up of Mammography: Harnessing the Power of Big Data in Health Care.
Murphy DR; Meyer AND; Vaghani V; Russo E; Sittig DF; Wei L; Wu L; Singh H
J Am Coll Radiol; 2018 Feb; 15(2):287-295. PubMed ID: 29102539
[TBL] [Abstract][Full Text] [Related]
9. Sex and the Diagnostic Pathway to Bladder Cancer among Veterans: No Evidence of Disparity.
Lynch KE; Viernes B; Khader K; DuVall SL; Schroeck FR
Womens Health Issues; 2020; 30(2):128-135. PubMed ID: 31870696
[TBL] [Abstract][Full Text] [Related]
10. Hematuria screening test for urinary bladder mucosal infiltration in cervical cancer.
Chuttiangtum A; Udomthavornsuk B; Chumworathayi B
Asian Pac J Cancer Prev; 2012; 13(10):4931-3. PubMed ID: 23244084
[TBL] [Abstract][Full Text] [Related]
11. Identification of patients with microscopic hematuria who are at greater risk for the presence of bladder tumors using a dedicated questionnaire and point of care urine test--a study by the members of Association of Urooncology, Turkey.
Turkeri L; Mangir N; Gunlusoy B; Yildirim A; Baltaci S; Kaplan M; Bozlu M; Mungan A
Asian Pac J Cancer Prev; 2014; 15(15):6283-6. PubMed ID: 25124612
[TBL] [Abstract][Full Text] [Related]
12. Electronic Detection of Delayed Test Result Follow-Up in Patients with Hypothyroidism.
Meyer AND; Murphy DR; Al-Mutairi A; Sittig DF; Wei L; Russo E; Singh H
J Gen Intern Med; 2017 Jul; 32(7):753-759. PubMed ID: 28138875
[TBL] [Abstract][Full Text] [Related]
13. Prospective external validation of a bladder cancer detection model.
Lotan Y; Svatek RS; Krabbe LM; Xylinas E; Klatte T; Shariat SF
J Urol; 2014 Nov; 192(5):1343-8. PubMed ID: 24859442
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of a bladder cancer screening program using home hematuria testing and molecular markers.
Bangma CH; Loeb S; Busstra M; Zhu X; El Bouazzaoui S; Refos J; Van Der Keur KA; Tjin S; Franken CG; van Leenders GJ; Zwarthoff EC; Roobol MJ
Eur Urol; 2013 Jul; 64(1):41-7. PubMed ID: 23478169
[TBL] [Abstract][Full Text] [Related]
15. Cancer Evaluations During the COVID-19 Pandemic: An Observational Study Using National Veterans Affairs Data.
Meyer AND; Singh H; Zimolzak AJ; Wei L; Choi DT; Marinez AD; Murphy DR
Am J Prev Med; 2022 Dec; 63(6):1026-1030. PubMed ID: 36055880
[TBL] [Abstract][Full Text] [Related]
16. What is evaluation of hematuria by primary care physicians? Use of electronic medical records to assess practice patterns with intermediate follow-up.
Buteau A; Seideman CA; Svatek RS; Youssef RF; Chakrabarti G; Reed G; Bhat D; Lotan Y
Urol Oncol; 2014 Feb; 32(2):128-34. PubMed ID: 23153858
[TBL] [Abstract][Full Text] [Related]
17. Optimal Trial Design for Studying Urinary Markers in Bladder Cancer: A Collaborative Review.
Lotan Y; Black PC; Caba L; Chang SS; Cookson MS; Daneshmand S; Kamat AM; McKiernan JM; Pruthi RS; Ritch CR; Steinberg GD; Svatek RS; Zwarthoff EC
Eur Urol Oncol; 2018 Aug; 1(3):223-230. PubMed ID: 31102625
[TBL] [Abstract][Full Text] [Related]
18. Use of a multitarget fluorescence in situ hybridization assay to diagnose bladder cancer in patients with hematuria.
Sarosdy MF; Kahn PR; Ziffer MD; Love WR; Barkin J; Abara EO; Jansz K; Bridge JA; Johansson SL; Persons DL; Gibson JS
J Urol; 2006 Jul; 176(1):44-7. PubMed ID: 16753364
[TBL] [Abstract][Full Text] [Related]
19. High-risk patients with hematuria are not evaluated according to guideline recommendations.
Elias K; Svatek RS; Gupta S; Ho R; Lotan Y
Cancer; 2010 Jun; 116(12):2954-9. PubMed ID: 20564400
[TBL] [Abstract][Full Text] [Related]
20. A noninvasive multianalyte urine-based diagnostic assay for urothelial cancer of the bladder in the evaluation of hematuria.
Karnes RJ; Fernandez CA; Shuber AP
Mayo Clin Proc; 2012 Sep; 87(9):835-42. PubMed ID: 22883743
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
